A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects
- PMID: 20647410
- PMCID: PMC2919621
- DOI: 10.1158/1055-9965.EPI-10-0288
A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects
Abstract
Background: Electronic "cigarettes" are marketed to tobacco users as potential reduced exposure products (PREP), albeit with little information regarding electronic cigarette user toxicant exposure and effects. This information may be obtained by adapting clinical laboratory methods used to evaluate other PREPs for smokers.
Methods: Thirty-two smokers participated in four independent Latin-square ordered conditions that differed by product: own brand cigarette, "NPRO" electronic cigarettes (NPRO EC; 18 mg cartridge), "Hydro" electronic cigarettes (Hydro EC; 16 mg cartridge), or sham (unlit cigarette). Participants took 10 puffs at two separate times during each session. Plasma nicotine and carbon monoxide (CO) concentration, heart rate, and subjective effects were assessed.
Results: Own brand significantly increased plasma nicotine and CO concentration and heart rate within the first five minutes of administration whereas NPRO EC, Hydro EC, and sham smoking did not. Own brand, NPRO EC, and Hydro EC (but not sham) significantly decreased tobacco abstinence symptom ratings and increased product acceptability ratings. The magnitude of symptom suppression and increased acceptability was greater for own brand than for NPRO EC and Hydro EC.
Conclusions: Under these acute testing conditions, neither of the electronic cigarettes exposed users to measurable levels of nicotine or CO, although both suppressed nicotine/tobacco abstinence symptom ratings.
Impact: This study illustrates how clinical laboratory methods can be used to understand the acute effects of these and other PREPs for tobacco users. The results and methods reported here will likely be relevant to the evaluation and empirically based regulation of electronic cigarettes and similar products.
(c)2010 AACR.
Figures



Similar articles
-
Evaluating the acute effects of oral, non-combustible potential reduced exposure products marketed to smokers.Tob Control. 2010 Oct;19(5):367-73. doi: 10.1136/tc.2008.028993. Epub 2009 Apr 2. Tob Control. 2010. PMID: 19346218 Free PMC article. Clinical Trial.
-
Clinical laboratory assessment of the abuse liability of an electronic cigarette.Addiction. 2012 Aug;107(8):1493-500. doi: 10.1111/j.1360-0443.2012.03791.x. Epub 2012 May 8. Addiction. 2012. PMID: 22229871 Free PMC article.
-
Acute effects of Advance: a potential reduced exposure product for smokers.Tob Control. 2002 Dec;11(4):376-8. doi: 10.1136/tc.11.4.376. Tob Control. 2002. PMID: 12432165 Free PMC article.
-
Expanding clinical laboratory tobacco product evaluation methods to loose-leaf tobacco vaporizers.Drug Alcohol Depend. 2016 Dec 1;169:33-40. doi: 10.1016/j.drugalcdep.2016.10.005. Epub 2016 Oct 11. Drug Alcohol Depend. 2016. PMID: 27768968 Free PMC article.
-
Electronic cigarettes for smoking cessation.Cochrane Database Syst Rev. 2021 Apr 29;4(4):CD010216. doi: 10.1002/14651858.CD010216.pub5. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2021 Sep 14;9:CD010216. doi: 10.1002/14651858.CD010216.pub6. PMID: 33913154 Free PMC article. Updated.
Cited by
-
Levels of selected carcinogens and toxicants in vapour from electronic cigarettes.Tob Control. 2014 Mar;23(2):133-9. doi: 10.1136/tobaccocontrol-2012-050859. Epub 2013 Mar 6. Tob Control. 2014. PMID: 23467656 Free PMC article.
-
The importance of science-informed policy and what the data really tell us about e-cigarettes.Isr J Health Policy Res. 2015 May 15;4:22. doi: 10.1186/s13584-015-0021-z. eCollection 2015. Isr J Health Policy Res. 2015. PMID: 26075054 Free PMC article.
-
Nicotine absorption from electronic cigarette use: comparison between experienced consumers (vapers) and naïve users (smokers).Sci Rep. 2015 Jun 17;5:11269. doi: 10.1038/srep11269. Sci Rep. 2015. PMID: 26082330 Free PMC article.
-
Vaporous Marketing: Uncovering Pervasive Electronic Cigarette Advertisements on Twitter.PLoS One. 2016 Jul 13;11(7):e0157304. doi: 10.1371/journal.pone.0157304. eCollection 2016. PLoS One. 2016. PMID: 27410031 Free PMC article.
-
Technology-based contingency management and e-cigarettes during the initial weeks of a smoking quit attempt.J Appl Behav Anal. 2019 Oct;52(4):928-943. doi: 10.1002/jaba.641. Epub 2019 Oct 2. J Appl Behav Anal. 2019. PMID: 31578724 Free PMC article.
References
-
- Pederson LL, Nelson DE. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: communication implications. Nicotine Tob Res. 2007;9(5):525–534. - PubMed
-
- O’Connor RJ, Hyland A, Giovino GA, Fong GT, Cummings KM. Smoker awareness of and beliefs about supposedly less-harmful tobacco products. Am J Prev Med. 2005;29(2):85–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous